Dr Reddy’s (NYSE: RDY) executive discloses direct holding of 70 shares

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD executive Sushrut Kulkarni, Global Head - IPDO, filed an initial ownership report showing beneficial ownership of 70 Equity Shares of the company. These shares are reported as held under direct ownership, with no buy or sell transaction disclosed in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KULKARNI SUSHRUT

Role GLOBAL HEAD - IPDO

Type	Security	Shares	Price	Value
holding	Equity Shares	--	--	--

Holdings After Transaction: Equity Shares — 70 shares (Direct)

Footnotes (1)

Key Figures

Shares beneficially owned: 70 Equity Shares

1 metrics

Shares beneficially owned 70 Equity Shares Total shares following reported holding

Key Terms

Form 3, Equity Shares, direct ownership

3 terms

Form 3 regulatory

"executive Sushrut Kulkarni, Global Head - IPDO, filed an initial ownership report"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Equity Shares financial

"beneficial ownership of 70 Equity Shares of the company"

Equity shares are units of ownership in a company that give the holder a claim on a portion of its assets and profits, like owning a slice of a business. They matter to investors because their value can rise or fall with the company’s performance and market sentiment, may provide periodic income through dividends, and often carry voting rights that influence how the business is run.

direct ownership financial

"These shares are reported as held under direct ownership"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KULKARNI SUSHRUT

(Last) (First) (Middle)

F NO. H-903, APARNA SERENE PARK,

SURVEY NO 146, KONDAPUR

(Street)

HYDERABAD TELANGANA 500084

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GLOBAL HEAD - IPDO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares	70	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ SUSHRUT KULKARNI	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the DR REDDYS LABORATORIES (RDY) Form 3 filing report?

The Form 3 reports initial insider holdings of 70 Equity Shares. Executive Sushrut Kulkarni, Global Head - IPDO, discloses direct beneficial ownership, providing a baseline of his equity position before any future reportable transactions occur.

How many DR REDDYS LABORATORIES (RDY) shares does Sushrut Kulkarni report on Form 3?

Sushrut Kulkarni reports beneficial ownership of 70 Equity Shares. The filing lists these 70 shares as the total amount directly owned following the reported position, with no separate transaction amounts or prices indicated.

Is there any buy or sell transaction in the DR REDDYS (RDY) Form 3 for Sushrut Kulkarni?

No buy or sell transaction is disclosed in this Form 3. The entry is categorized as a holding, establishing that Kulkarni directly owns 70 Equity Shares without indicating a recent purchase or sale event.

What type of security is reported in the DR REDDYS (RDY) Form 3 for Sushrut Kulkarni?

The filing reports holdings in Equity Shares of DR REDDYS. These Equity Shares represent the common equity security of the issuer, and the Form 3 records 70 such shares under Kulkarni’s direct ownership.

What is the ownership nature of the DR REDDYS (RDY) shares reported by Sushrut Kulkarni?

The 70 Equity Shares are reported as directly owned. The filing marks the ownership type as direct, meaning the shares are attributed personally to Kulkarni rather than through an intermediary entity or indirect holding structure.